Leukemia, Lymphoid D007945

Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Lymphoproliferative Disorders » Leukemia, Lymphoid

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Leukemia » Leukemia, Lymphoid

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Leukemia, Lymphoid

Description

Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.   MeSH

Subtype Terms (5)

Leukemia, B-Cell
105 drugs (46 approved, 59 experimental)

Leukemia, Biphenotypic, Acute
63 drugs (43 approved, 20 experimental)

Leukemia, Prolymphocytic
69 drugs (46 approved, 23 experimental)

Leukemia, T-Cell
32 drugs (23 approved, 9 experimental)

Precursor Cell Lymphoblastic Leukemia-Lymphoma
358 drugs (163 approved, 195 experimental)


Approved Indicated Drugs (1)


Organization Involved with Phase 4 Indications (63)

Organization Involved with Phase 3 Indications (180)

Organization Involved with Phase 2 Indications (326)

Abbott

Academic and Community Cancer Research United

Acibadem University

Acrotech Biopharma LLC

ADC Therapeutics SARL

Aegera Therapeutics

Ain Shams University

Alberta Cancer Foundation

Alexion

American Cancer Society, Inc.

Ångstrom Pharmaceuticals

Anhui Medical University

AO GENERIUM

Aprea Therapeutics AB

Aptevo Therapeutics

Ariad Pharmaceuticals

Asana BioSciences

Ascentage Pharma Group Inc.

Ascenta Therapeutics

ASL della provincia

Assisi Foundation

Assistance Publique - Hôpitaux de Paris

Autolus Limited

Azienda Ospedaliera Antonio Cardarelli

Azienda Ospedaliera Ospedale Civile di Legnano

Azienda Osperdaliera Vincenzo Cervello Divisione

Azienda ULSS 12 Veneziana

AZ Sint-Jan

Bambino Gesù Hospital and Research Institute

Bayer

Baylor University

Beijing Boren Hospital

Bellicum Pharmaceuticals

Betta Pharmaceuticals Co.,Ltd.

BioCryst

Bioenvision

Biologics, Inc.

BioSight Ltd.

Boston University

CABYC

Callisto Pharmaceuticals

Canadian Cancer Trials Group

Cancer Biotherapy Research Group

CancerCare Manitoba

Cardiff University

Case Western Reserve University

Catholic University of Korea

Cellgenix

Centaurus Biopharma Co., Ltd.

Centre Henri Becquerel

Centre Leon Berard

Centro Goiano de Oncologia

Cephalon

Children's National Medical Center

Chinese University of Hong Kong

Chongqing Medical University

Chongqing Precision Biotech Co., Ltd

Chonnam National University

Chronic Lymphocytic Leukemia Research Consortium

Chu De Liège

CHU Hart Leveque

CHU Mont-Godinne

City of Hope National Medical Center

CLL Topics

Complessa di Ematologia and Dir Departmento

Cookies for Kids' Cancer

CTI BioPharma

Cyclacel Pharmaceuticals, Inc.

Cylene Pharmaceuticals

CytRx

CZECRIN - Czech Clinical Research Infrastructure Network

Department of Health, United Kingdom

DKMS Stiftung Leben Spenden

Edwards Foundation, Inc.

Eisai

Eleos, Inc.

Emergent BioSolutions

Emory University

European Intergroup Study on Post Induction Treatment of Philadelphia Positive Acute Lymphoblastic Leukaemia with Imatinib

Faculdade de Medicina do ABC

Fate Therapeutics

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Federal University of Rio de Janeiro

Federal University of Rio Grande do Sul

First People's Hospital of Foshan

Fondazione Giovanni Pascale

Fondazione Matilde Tettamanti Menotti De Marchi Onlus

Food and Drug Administration

Free State University

Fundacao Hospital Amaral Carvalho

Fundació Sant Joan de Déu

Gateway for Cancer Research

Genitope Corporation

Georgetown University

German Cancer Research Center

Ghent University

GMP BIO Co., LTD.

Gottfried Wilhelm Leibniz Universität Hannover

Government of Brazil

Government of France

Government of Japan

Government of Mexico

Government of Spain

Grupo Cooperativo de Hemopatías Malignas

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Grupo Espanol de trasplantes hematopoyeticos y terapia celular

Guangdong Pharmaceutical University

Guangxi Medical University

Hackensack University Medical Center

Hefei University

Henan Medical University

Henan University of Traditional Chinese Medicine

Herbert Irving Comprehensive Cancer Center

Hoag Memorial Hospital Presbyterian

HOANNJ-Carol G. Simon Cancer Center

Hospital Brigadeiro

Hospital de Clinicias da UICAMP

Hospital Erasto Gaertner

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Hospital Nossa Senhora da Conceicao

Hospital Santa Marcelina, Sao Paulo, Brasil

Humboldt University

iCarTAB BioMed Inc.

Immunomedics

INC Research

Indiana University

Infinity Pharmaceuticals, Inc.

Inje University

Innate Pharma

Innovative Therapies For Children with Cancer Consortium

Institut de Cancérologie de la Loire (ICLN)

Institut de Cancerologie de l'Ouest Paul Papin

Institute of Hematology and Blood Transfusion, Czech Republic

Instituto de Oncologia Pediatrica - GRAACC Grupo de Apoio as Adolescente e a Crianca com Cancer - UNIFESP

Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti

Instituto Mexicano del Seguro Social

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Institut Paoli-Calmettes

Invectys

IO Biotech

Iovance

Istituti Ospitalieri di Cremona

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istitutp di Ematologia ed Oncologia Medica

Italfarmaco

James Graham Brown Cancer Center

JP Moulton Charitable Foundation

Julius-Maximilians University

Juno Therapeutics, Inc.

Juventas Therapeutics, Inc.

Kansas Bioscience Authority

Kartos Therapeutics, Inc.

Keryx

Kite Pharma, Inc.

Klinika Okulistyki

Korea Research Institute of Bioscience and Biotechnology

Kyowa Hakko Kirin

La Jolla Pharmaceutical Company

Leadiant Biosciences, Inc.

Liberty Hematology and Oncology

Ligand Pharmaceuticals

Louisiana State University

Ludwig Maximilians University

Lymphoma Research Foundation

Marshall University

Matinas Biopharma, Inc

McGill University

Medical University of South Carolina

MedImmune

Memgen, LLC

Memorial Sloan-Kettering Cancer Center

Mesoblast, Inc.

Methodist Cancer Center, Houston, Texas

MethylGene Inc.

Miltenyi Biotec, Inc.

Mirati Therapeutics Inc.

MorphoSys

Nanchang University

National Cancer Center, Japan

National Comprehensive Cancer Network

National Hospital Organisation Nagoya Medical Centre

National Institute on Aging (NIA)

National Marrow Donor Program

Nevada Cancer Institute

Newcastle University

New York Medical College

Nordic CLL Study Group

North Central Cancer Treatment Group

Northside Hospital, Inc.

Northwell Health

Novacea

Noxxon AG

OHSU Knight Cancer Institute

Onconova Therapeutics, Inc.

Oncternal Therapeutics

Oshadi Drug Administration

OSI Pharmaceuticals

Ospedale di Bergamo

Ospedale S. Giovanni Bellinzona

Ospedale Valduce, Como

Pavlov First Saint Petersburg State Medical University

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Pierre Fabre

Point Therapeutics

Portola Pharmaceuticals

Precision BioSciences, Inc.

Presidio Ospedaliero Spedali Civili di Brescia

Proacta, Incorporated

Regione Lombardia

Renato Melaragno

Rhizen Pharmaceuticals SA

Rio de Janeiro Federal University

Sanofi

Santaris Pharma A/S

Santobono - Pausilipon Hospital

Schering

Schering AG

Schering-Plough

SCRI Development Innovations

Scripps

Seattle Genetics

Seoul National University

Service Clinique des Maladies du Sang

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Shanghai Zhangjiang Biotechnology Limited Company

Shenzhen BinDeBio Ltd.

Shenzhen Institute for Innovation and Translational Medicine

Simcere Pharmaceutical Co., Ltd

Spirogen

Stanford University

State University of New York, Buffalo

St. Baldrick's Foundation

Sunesis Pharmaceuticals

SymBio Pharmaceuticals

Takara Bio Inc.

Takeda

TCR2 Therapeutics

Teaching Hospital Královské Vinohrady (FNKV)

Technical University of Dresden

Technical University of Munich

Texas Oncology Cancer Center

The EMMES Corporation

The Foundation Institute San Raffaele G. Giglio of Cefalù

The Korean Society of Pediatric Hematology Oncology

The Leukemia and Lymphoma Society

The Lymphoma Academic Research Organisation

Theradex

The Royal Bournemouth Hospital

The Scientific and Technological Research Council of Turkey

The Wayne D. Kuni and Joan E. Kuni Foundation

Thomas Jefferson University

Titan Pharmaceuticals

Tolero Pharmaceuticals

Universidad Autonoma de Madrid

Universidade Federal do Parana

Universita Degli Studi La Sapeinza

Universitair Ziekenhuis Gent

Université catholique de Louvain

University Clermont Auvergne

University Hospital Brno

University Hospital Hradec Kralove

University of Adelaide

University of Alabama, Birmingham

University of Alberta

University of Amsterdam

University of Antwerp

University of Birmingham

University of Brescia

University of Bristol

University of British Columbia

University of California, Davis

University of California, San Diego

University of California, San Francisco

University of Chicago

University of Colorado, Denver

University of Duesseldorf

University of Florida

University of Gothenburg

University of Hamburg

University of Heidelberg

University of Kansas

University of Kentucky

University of Leeds

University of Louisville

University of Lyon

University of Manitoba

University of Medicine and Dentistry of New Jersey

University of Miami

University of Michigan

University of Munster

University of Nantes

University of Nebraska

University of Oulu

University of Palermo

University of Perugia

University of Regensburg

University of Rennes

University of Roma La Sapienza

University of Rostock

University of Salzburg

University of Sao Paulo

University of South Carolina

University of Southern California

University of Toronto

University of Tuebingen

University of Ulm

University of Ulsan

University of Utah

University of Vermont

University of Versailles

U.O. di Ematologia- Ospedale dell'Angelo - Mestre

Valerio

Vanderbilt University

Vastra Gotaland Region

Vical

Vilnius University

Vion Pharmaceuticals

Virginia Commonwealth University

Vita-Salute University of Milano. Italy

Wake Forest University

Washington University in St. Louis

Wayne State University

Yale University

Yeshiva University

Zhejiang DTRM Biopharma

ZNA Antwerpen

Organization Involved with Phase 1 Indications (102)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.